Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Feb;51(2):292-8.

Complement-mediated inhibition of immune precipitation in patients with immune complex diseases

Complement-mediated inhibition of immune precipitation in patients with immune complex diseases

J K Naama et al. Clin Exp Immunol. 1983 Feb.

Abstract

The ability of human sera to prevent the precipitation of antigen-antibody complexes has been investigated. The early complement components including C3 are required for optimal prevention of immune precipitation, whereas the later components are not required. The sera of 36 of 75 patients with seropositive rheumatoid arthritis (RA), 14 of 32 with SLE and four of 17 with glomerulonephritis exhibited reduced capacities to prevent immune precipitation. In contrast sera from patients with seronegative RA, ankylosing spondylitis, psoriatic arthritis or degenerative joint disease were normal in this respect. In SLE and GN sera hypocomplementaemia was frequently associated but not always with failure to prevent immune precipitation, whereas only a small proportion of the patients with seropositive RA and reduced capacity to retain complexes in a soluble form were hypocomplementaemic. Thus the failure of sera to prevent the precipitation of antigen-antibody complexes is not always associated with hypocomplementaemia.

PubMed Disclaimer

References

    1. Bull Rheum Dis. 1958 Dec;9(4):175-6 - PubMed
    1. Am J Trop Med Hyg. 1963 Jan;12:103-16 - PubMed
    1. Clin Exp Immunol. 1982 Mar;47(3):555-62 - PubMed
    1. Int Arch Allergy Appl Immunol. 1966;29(2):185-9 - PubMed
    1. J Clin Lab Immunol. 1982 Jan;7(1):15-9 - PubMed

Publication types

Substances

LinkOut - more resources